Annual Accounts Payable
$5.55 M
-$893.00 K-13.85%
December 31, 2023
Summary
- As of February 12, 2025, HBIO annual accounts payable is $5.55 million, with the most recent change of -$893.00 thousand (-13.85%) on December 31, 2023.
- During the last 3 years, HBIO annual accounts payable has fallen by -$418.00 thousand (-7.00%).
- HBIO annual accounts payable is now -36.76% below its all-time high of $8.78 million, reached on December 31, 2015.
Performance
HBIO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.28 M
-$428.00 K-7.49%
September 30, 2024
Summary
- As of February 12, 2025, HBIO quarterly accounts payable is $5.28 million, with the most recent change of -$428.00 thousand (-7.49%) on September 30, 2024.
- Over the past year, HBIO quarterly accounts payable has dropped by -$986.00 thousand (-15.73%).
- HBIO quarterly accounts payable is now -55.85% below its all-time high of $11.97 million, reached on September 30, 2003.
Performance
HBIO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
HBIO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.8% | -15.7% |
| 3 y3 years | -7.0% | -5.9% |
| 5 y5 years | -24.5% | +0.3% |
HBIO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.8% | +13.1% | -22.4% | +12.0% |
| 5 y | 5-year | -13.8% | +13.1% | -29.5% | +12.0% |
| alltime | all time | -36.8% | +195.4% | -55.9% | +149.5% |
Harvard Bioscience Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.28 M(-7.5%) |
| Jun 2024 | - | $5.71 M(-5.5%) |
| Mar 2024 | - | $6.04 M(+8.8%) |
| Dec 2023 | $5.55 M(-13.9%) | $5.55 M(-11.4%) |
| Sep 2023 | - | $6.27 M(+32.9%) |
| Jun 2023 | - | $4.72 M(-21.1%) |
| Mar 2023 | - | $5.98 M(-7.3%) |
| Dec 2022 | $6.45 M(+31.3%) | $6.45 M(+9.7%) |
| Sep 2022 | - | $5.88 M(-13.7%) |
| Jun 2022 | - | $6.81 M(+9.5%) |
| Mar 2022 | - | $6.22 M(+26.6%) |
| Dec 2021 | $4.91 M(-17.8%) | $4.91 M(-12.6%) |
| Sep 2021 | - | $5.62 M(-25.0%) |
| Jun 2021 | - | $7.49 M(+16.7%) |
| Mar 2021 | - | $6.42 M(+7.4%) |
| Dec 2020 | $5.97 M(+11.9%) | $5.97 M(-0.3%) |
| Sep 2020 | - | $5.99 M(-9.2%) |
| Jun 2020 | - | $6.60 M(-0.4%) |
| Mar 2020 | - | $6.63 M(+24.1%) |
| Dec 2019 | $5.34 M(-27.4%) | $5.34 M(+1.4%) |
| Sep 2019 | - | $5.27 M(-12.8%) |
| Jun 2019 | - | $6.04 M(-17.4%) |
| Mar 2019 | - | $7.31 M(-0.7%) |
| Dec 2018 | $7.36 M(+66.9%) | $7.36 M(+36.5%) |
| Sep 2018 | - | $5.39 M(-30.1%) |
| Jun 2018 | - | $7.72 M(+4.9%) |
| Mar 2018 | - | $7.36 M(+66.9%) |
| Dec 2017 | $4.41 M(-28.8%) | $4.41 M(-21.3%) |
| Sep 2017 | - | $5.61 M(+0.4%) |
| Jun 2017 | - | $5.58 M(-4.3%) |
| Mar 2017 | - | $5.83 M(-5.8%) |
| Dec 2016 | $6.20 M(-29.4%) | $6.20 M(+0.9%) |
| Sep 2016 | - | $6.14 M(-6.6%) |
| Jun 2016 | - | $6.58 M(+6.6%) |
| Mar 2016 | - | $6.17 M(-29.7%) |
| Dec 2015 | $8.78 M(+39.5%) | $8.78 M(+38.9%) |
| Sep 2015 | - | $6.32 M(-28.4%) |
| Jun 2015 | - | $8.83 M(+23.0%) |
| Mar 2015 | - | $7.18 M(+14.1%) |
| Dec 2014 | $6.29 M(+34.4%) | $6.29 M(+24.6%) |
| Sep 2014 | - | $5.05 M(-0.2%) |
| Jun 2014 | - | $5.06 M(+8.4%) |
| Mar 2014 | - | $4.67 M(-0.3%) |
| Dec 2013 | $4.68 M(+0.0%) | $4.68 M(+0.5%) |
| Sep 2013 | - | $4.66 M(-4.5%) |
| Jun 2013 | - | $4.88 M(+10.1%) |
| Mar 2013 | - | $4.43 M(-5.4%) |
| Dec 2012 | $4.68 M | $4.68 M(+13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $4.14 M(-10.1%) |
| Jun 2012 | - | $4.61 M(-6.4%) |
| Mar 2012 | - | $4.92 M(-0.8%) |
| Dec 2011 | $4.96 M(+0.8%) | $4.96 M(-5.8%) |
| Sep 2011 | - | $5.26 M(-1.9%) |
| Jun 2011 | - | $5.37 M(-6.3%) |
| Mar 2011 | - | $5.72 M(+16.3%) |
| Dec 2010 | $4.92 M(+1.3%) | $4.92 M(+4.0%) |
| Sep 2010 | - | $4.73 M(-4.2%) |
| Jun 2010 | - | $4.94 M(+0.1%) |
| Mar 2010 | - | $4.94 M(+1.7%) |
| Dec 2009 | $4.86 M(+4.1%) | $4.86 M(+12.8%) |
| Sep 2009 | - | $4.30 M(+28.2%) |
| Jun 2009 | - | $3.36 M(-7.6%) |
| Mar 2009 | - | $3.63 M(-22.1%) |
| Dec 2008 | $4.67 M(-16.9%) | $4.67 M(+19.4%) |
| Sep 2008 | - | $3.91 M(-25.7%) |
| Jun 2008 | - | $5.26 M(-7.5%) |
| Mar 2008 | - | $5.69 M(+1.4%) |
| Dec 2007 | $5.61 M(+25.0%) | $5.61 M(+69.4%) |
| Sep 2007 | - | $3.31 M(-6.3%) |
| Jun 2007 | - | $3.53 M(-10.3%) |
| Mar 2007 | - | $3.94 M(-12.3%) |
| Dec 2006 | $4.49 M(+11.5%) | $4.49 M(+27.3%) |
| Sep 2006 | - | $3.53 M(+5.2%) |
| Jun 2006 | - | $3.35 M(-14.4%) |
| Mar 2006 | - | $3.92 M(-2.8%) |
| Dec 2005 | $4.03 M(-35.6%) | $4.03 M(+30.4%) |
| Sep 2005 | - | $3.09 M(-43.6%) |
| Jun 2005 | - | $5.47 M(-15.6%) |
| Mar 2005 | - | $6.49 M(+3.7%) |
| Dec 2004 | $6.25 M(-3.2%) | $6.25 M(+24.2%) |
| Sep 2004 | - | $5.03 M(-3.7%) |
| Jun 2004 | - | $5.22 M(-13.5%) |
| Mar 2004 | - | $6.04 M(-6.5%) |
| Dec 2003 | $6.46 M(+16.9%) | $6.46 M(-46.0%) |
| Sep 2003 | - | $11.97 M(+71.0%) |
| Jun 2003 | - | $7.00 M(+19.4%) |
| Mar 2003 | - | $5.86 M(+6.1%) |
| Dec 2002 | $5.53 M(+78.2%) | $5.53 M(+77.8%) |
| Sep 2002 | - | $3.11 M(-2.3%) |
| Jun 2002 | - | $3.18 M(-1.1%) |
| Mar 2002 | - | $3.22 M(+3.8%) |
| Dec 2001 | $3.10 M(+46.4%) | $3.10 M(+42.3%) |
| Sep 2001 | - | $2.18 M(-27.8%) |
| Jun 2001 | - | $3.02 M(+26.3%) |
| Mar 2001 | - | $2.39 M(+12.8%) |
| Dec 2000 | $2.12 M(+12.6%) | $2.12 M |
| Dec 1999 | $1.88 M | - |
FAQ
- What is Harvard Bioscience annual accounts payable?
- What is the all time high annual accounts payable for Harvard Bioscience?
- What is Harvard Bioscience annual accounts payable year-on-year change?
- What is Harvard Bioscience quarterly accounts payable?
- What is the all time high quarterly accounts payable for Harvard Bioscience?
- What is Harvard Bioscience quarterly accounts payable year-on-year change?
What is Harvard Bioscience annual accounts payable?
The current annual accounts payable of HBIO is $5.55 M
What is the all time high annual accounts payable for Harvard Bioscience?
Harvard Bioscience all-time high annual accounts payable is $8.78 M
What is Harvard Bioscience annual accounts payable year-on-year change?
Over the past year, HBIO annual accounts payable has changed by -$893.00 K (-13.85%)
What is Harvard Bioscience quarterly accounts payable?
The current quarterly accounts payable of HBIO is $5.28 M
What is the all time high quarterly accounts payable for Harvard Bioscience?
Harvard Bioscience all-time high quarterly accounts payable is $11.97 M
What is Harvard Bioscience quarterly accounts payable year-on-year change?
Over the past year, HBIO quarterly accounts payable has changed by -$986.00 K (-15.73%)